Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
With
REGENXBIO Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Must provide written, signed informed consent for this study.
2. Must have been enrolled in a previous clinical study of ABBV-RGX-314 in the treatment of nAMD and must have received an SCS injection of ABBV-RGX-314 in that study.
3. Must be willing and able to comply with all study procedures.
You may not be if
1\. None
Clareo Health | Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
